|
| | Publication Year | Title | Author(s) |
| 1 | Jul-2022 | Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre. | Tam, Constantine S; Gregory, Gareth P; Ku, Matthew; Fleming, Shaun; Handunnetti, Sasanka M; Lee, Denise; Walker, Patricia; Perkins, Andrew; Lew, Thomas E; Sirdesai, Shreerang; Chua, Chong Chyn ; Gilbertson, Michael; Lasica, Masa; Anderson, Mary Ann; Renwick, William; Grigg, Andrew P ; Patil, Sush; Opat, Stephen; Friebe, Adam; Cooke, Rachel; De Boer, Jasper; Spencer, Andrew; Ritchie, David; Agarwal, Rishu ; Blombery, Piers |
| 2 | Jan-2020 | Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation. | Wong, Eric ; Davis, Joanne; Koldej, Rachel; Szer, Jeff; Grigg, Andrew P ; Ritchie, David |
| 3 | 12-Aug-2019 | New Advances in the Management of Cytomegalovirus in Allogeneic Haemopoietic Stem Cell Transplantation. | Yong, Michelle K; Gottlieb, David; Lindsay, Julian; Kok, Jen; Rawlinson, William; Slavin, Monica; Ritchie, David; Bajel, Ashish; Grigg, Andrew P |
| 4 | 2019 | Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation. | Wong, Eric ; Davis, Joanne E; Grigg, Andrew P ; Szer, Jeff; Ritchie, David |
| 5 | Dec-2018 | The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients. | Willcox, Abbey ; Wong, Eric ; Nath, Christa; Janson, Brett; Harrison, Simon J; Hoyt, Rosemary; Bajel, Ashish; Shaw, Peter; Ritchie, David; Grigg, Andrew P |
| 6 | 2-May-2018 | Prognostic Markers in Core-Binding Factor AML and Improved Survival with Multiple Consolidation Cycles of Intermediate/High-dose Cytarabine. | Prabahran, Ashvind; Tacey, Mark A ; Fleming, Shaun; Wei, Andrew; Tate, Courtney; Marlton, Paula; Wight, Joel C ; Grigg, Andrew P ; Tuckfield, Annabel; Szer, Jeff; Ritchie, David; Chee, Lynette |
| 7 | Jan-2017 | Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea | Douglas, Genevieve ; Harrison, Claire; Forsyth, Cecily J; Bennett, Michael R; Stevenson, William; Hounsell, John; Ratnasingam, Sumita; Ritchie, David; Ross, David M; Grigg, Andrew P |
| 8 | Dec-2016 | Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience | Jeong, Wirawan; Haywood, Peter; Shanmuganathan, Naranie; Lindsay, Julian; Urbancic, Karen; Ananda-Rajah, Michelle R; Chen, Sharon CA; Bajel, Ashish; Ritchie, David; Grigg, Andrew P ; Seymour, John F; Peleg, Anton Y; Kong, David CM; Slavin, Monica A |
Loading...
2
0
20
0
false